News

Understandably, there is a lot of nervousness around how COVID-19 is going to affect the healthcare industry-both in the near-term as well as the distant future. As the organizations that will have to take on a majority of the financial and operational burden of the COVID pandemic, providers will be hit the hardest in the short-term. As a result, a majority of relief, both at federal and local levels, can be expected to be centered around rescuing providers post-COVID.

Former CareMore Health CEO Sachin Jain, MD, MBA, perhaps best known for his effort to treat loneliness among seniors as a health issue, has been named CEO of the SCAN Group and the SCAN Health Plan, a not-for-profit that focuses on this growing population.

Association of Diabetes Care and Education Specialists, chief science and practice officer, Leslie Kolb chats with MHE Associate Editor Briana Contreras in MHE's newest podcast Tuning into the C-Suite about diabetes management and how it's affected by the use of telehealth, especially during the current and trying times of the COVID-19 pandemic.

Drug makers around the world are racing to develop the first effective COVID-19 vaccine. Early efforts show promise, but an anticipated jump in the novel coronavirus cases in the fall means the sooner a vaccine is developed, the more lives can be saved-and the pharmaceutical industry plays a major role in this discovery.

Fast Healthcare Interoperability Resources, or FHIR, is a long-awaited interoperability rule that will enable seamless, on-demand information exchange of clinical records among providers and data systems and will result in coordinated, cost-efficient care.

During the American Society of Clinical Oncology 2020 Annual Meeting, Flatiron Health, Foundation Medicine, and Genentech presented plans for the Prospective Clinico-Genomic study (PCG), a low-interventional pilot that will use a technology-enabled prospective data collection platform to simplify data collection for patients with lung cancer being treated through clinical trials.